Immune checkpoints and cancer development: Therapeutic implications and future directions
Saber Mehdizadeh, Hashem Bayatipoor, Salar Pashangzadeh, Roghayeh Jafarpour, Zeinab Shojaei, Morteza Motallebnezhad
Topics & Concepts
IpilimumabBTLATIGITAtezolizumabNivolumabImmune systemPembrolizumabImmune checkpointCancer immunotherapyTremelimumabImmunotherapyImmunologyCytotoxic T cellCTLA-4Cancer researchT cellBiologyBiochemistryIn vitroCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy research